| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10137177 | Stem Cell Research | 2018 | 4 Pages |
Abstract
Myotonic dystrophy type 1 (DM1) is a dominantly inherited neurodegenerative disease caused by a CTG repeat expansion close to the DMPK gene. The fibroblasts from a patient with DM1 were successfully converted to induced pluripotent stem cells (iPSCs), designated ZZUi006-A, by employing episomal plasmids expressing OCT3/4, SOX2, KLF4, LIN28, L-MYC. The ZZUi006-A cell line may provide a robust platform for further study of DM1 pathogenesis as well as drug testing and gene therapy research.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Yanlin Wang, Zhilei Wang, Huifang Sun, Changhe Shi, Jing Yang, Yutao Liu, Han Liu, Shoutao Zhang, Li Zhang, Yuming Xu, Jin Zhang,